2.69
price up icon6.97%   0.18
after-market Handel nachbörslich: 2.66 -0.03 -1.12%
loading

Immunitybio Inc Aktie (IBRX) Neueste Nachrichten

pulisher
Apr 21, 2025

ImmunityBio to Showcase Advances for Bladder and Prostate Cancer at American Urological Association (AUA) Annual Meeting - BioSpace

Apr 21, 2025
pulisher
Apr 17, 2025

Why ImmunityBio, Inc. (IBRX) Declined on Wednesday - Yahoo Finance

Apr 17, 2025
pulisher
Apr 16, 2025

Economic Uncertainties Batter Trading in These 10 Firms - Insider Monkey

Apr 16, 2025
pulisher
Apr 15, 2025

ImmunityBio sees Q1 sales surge, submits FDA applications By Investing.com - Investing.com South Africa

Apr 15, 2025
pulisher
Apr 15, 2025

ImmunityBio Announces FDA Submissions of Supplemental BLA for NMIBC Papillary Disease and for Expanded Access of ANKTIVA® to Treat Lymphopenia - BioSpace

Apr 15, 2025
pulisher
Apr 15, 2025

ImmunityBio Completes FDA License Application Submissions - marketscreener.com

Apr 15, 2025
pulisher
Apr 15, 2025

Immunitybio Announces FDA Submissions Of Supplemental BLA For Nmibc Papillary Disease And For Expanded Access Of Anktiva®To Treat Lymphopenia - marketscreener.com

Apr 15, 2025
pulisher
Apr 15, 2025

ImmunityBio sees Q1 sales surge, submits FDA applications - Investing.com

Apr 15, 2025
pulisher
Apr 15, 2025

Why ImmunityBio Inc. (IBRX) Skyrocketed On Monday? - MSN

Apr 15, 2025
pulisher
Apr 14, 2025

Is ImmunityBio Stock Heading Upwards? - timothysykes.com

Apr 14, 2025
pulisher
Apr 09, 2025

ImmunityBio settles securities class action lawsuit for $10.5 million - Claim Depot

Apr 09, 2025
pulisher
Apr 09, 2025

ImmunityBio, Inc. (IBRX): Among Stocks Under $10 that Will Triple - Insider Monkey

Apr 09, 2025
pulisher
Apr 09, 2025

Why ImmunityBio Inc. (IBRX) Went Down On Tuesday? - Insider Monkey

Apr 09, 2025
pulisher
Apr 08, 2025

ImmunityBio secures $75 million in direct offering - Investing.com Australia

Apr 08, 2025
pulisher
Apr 08, 2025

ImmunityBio secures $75 million in direct offering By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 08, 2025

SEC Form 424B5 filed by ImmunityBio Inc. - Quantisnow

Apr 08, 2025
pulisher
Apr 08, 2025

ImmunityBio Stock: What’s Driving the Market? - timothysykes.com

Apr 08, 2025
pulisher
Apr 08, 2025

Rallybio ends development in rare disorder; ImmunityBio raises $75M - Endpoints News

Apr 08, 2025
pulisher
Apr 08, 2025

ImmunityBio Launches $75 Million Registered Direct Offering - MarketScreener

Apr 08, 2025
pulisher
Apr 08, 2025

ImmunityBio (IBRX) Secures $75 Million in Direct Offering - GuruFocus

Apr 08, 2025
pulisher
Apr 08, 2025

ImmunityBio raises $75 million in equity financing - MSN

Apr 08, 2025
pulisher
Apr 08, 2025

ImmunityBio Secures $75 Million in Direct Offering - TipRanks

Apr 08, 2025
pulisher
Apr 08, 2025

ImmunityBio Announces Execution of $75 Million Equity Financing with an Institutional Investor - Business Wire

Apr 08, 2025
pulisher
Apr 07, 2025

IMMUNITYBIO, INC. SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against ImmunityBio, Inc. (NASDAQ: IBRX) - ACCESS Newswire

Apr 07, 2025
pulisher
Apr 07, 2025

ImmunityBio to Host Key Opinion Leader and Investor Meeting to Provide Updates on Clinical Programs and ANKTIVA Commercial Launch - BioSpace

Apr 07, 2025
pulisher
Apr 04, 2025

Investor Alert: Wolfspeed, Driven Brands Holdings, Hasbro, - GlobeNewswire

Apr 04, 2025
pulisher
Apr 04, 2025

Investor Alert: Wolfspeed, Driven Brands Holdings, Hasbro, and ImmunityBio: Johnson Fistel, PLLP Investigates Claims on Behalf of Investors - TradingView

Apr 04, 2025
pulisher
Apr 03, 2025

ImmunityBio: Taking Care Of Business (NASDAQ:IBRX) - Seeking Alpha

Apr 03, 2025
pulisher
Apr 01, 2025

ImmunityBio and Beigene to run Phase 3 of Anktiva plus PD-1 in NSCLC - PPF Group

Apr 01, 2025
pulisher
Mar 29, 2025

Why ImmunityBio Inc. (IBRX) Went Up Last Week? - Yahoo Finance

Mar 29, 2025
pulisher
Mar 28, 2025

Is ImmunityBio, Inc. Stock a Buy Right Now? - timothysykes.com

Mar 28, 2025
pulisher
Mar 27, 2025

ImmunityBio’s Recent Surge: What’s Behind It? - timothysykes.com

Mar 27, 2025
pulisher
Mar 26, 2025

ImmunityBio to Host Investor Day - BioSpace

Mar 26, 2025
pulisher
Mar 25, 2025

Is ImmunityBio, Inc. (NASDAQ:IBRX) The Top Penny Stock That Will Skyrocket? - Insider Monkey

Mar 25, 2025
pulisher
Mar 24, 2025

Investor Alert: Wolfspeed, Driven Brands Holdings, Hasbro, and ImmunityBio: Johnson Fistel, PLLP Investigates - EIN News

Mar 24, 2025
pulisher
Mar 19, 2025

ImmunityBio appoints Deloitte as new auditor By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

ImmunityBio appoints Deloitte as new auditor - Investing.com Australia

Mar 19, 2025
pulisher
Mar 18, 2025

Drugmaker's $10.5M Deal In Investor FDA Approval Suit OK'd - Law360

Mar 18, 2025
pulisher
Mar 18, 2025

ImmunityBio $10.5 Million Settlement Over Record Selloff Gets OK - Bloomberg Law News

Mar 18, 2025
pulisher
Mar 18, 2025

From cancer vaccines to COPD treatments, these 10 companies are developing innovative medicines - Fast Company

Mar 18, 2025
$20.27
price up icon 0.92%
$71.24
price up icon 2.53%
$32.19
price up icon 0.11%
$27.35
price up icon 8.52%
$104.68
price up icon 2.82%
biotechnology ONC
$252.77
price up icon 10.52%
Kapitalisierung:     |  Volumen (24h):